MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, MIST has $193,734K in assets. $157,685K in debts. $71,317K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
917.94%
Quick Ratio
909.22%
Cash Ratio
340.51%
Debt to Asset Ratio
81.39%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Cash and cash equivalents
    • Accounts receivable, net
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Common shares, no par value, unl...
    • Royalty financing obligation, lo...
    • Others

Balance Sheets
2026-03-31
2025-09-30
2025-06-30
Cash and cash equivalents
71,317 46,685 42,499
Short-term investments
112,899 35,900 918
Accounts receivable, net
1,605 --
License receivable
1,546 --
Research and development tax credits receivable
425 808 1,079
Prepaid expenses
1,210 2,577 748
Inventory, net
1,826 --
Other receivables
1,425 700 924
Total current assets
192,253 86,670 46,168
Operating lease right-of-use assets
981 944 1,090
Property and equipment, net
500 136 159
Total assets
193,734 87,750 47,417
Accounts payable
10,023 --
Accounts payable and accrued liabilities
-10,041 8,768
Accrued liabilities
9,803 --
Operating lease liabilities
659 483 515
Deferred revenue
416 --
Other current liabilities
43 --
Total current liabilities
20,944 10,524 9,283
Operating lease liabilities, net of current portion
366 519 641
Senior secured convertible notes
58,192 56,206 55,238
Royalty financing obligation, long-term
78,111 --
Other long-term liabilities
72 --
Total liabilities
157,685 67,249 65,162
Common shares, no par value, unlimited shares authorized, 117,794,417 shares issued and outstanding as of march 31, 2026, 106,236,344 shares issued and outstanding as of december 31, 2025
373,702 311,776 288,263
Pre-funded warrants - 16,412,925 issued and outstanding as of march 31, 2026 and 16,412,925 as of december 31, 2025
55,649 55,649 53,076
Additional paid-in capital
63,367 66,270 42,188
Accumulated deficit
-456,669 -413,194 -401,272
Total shareholders' equity
36,049 20,501 -17,745
Total liabilities and shareholders' equity
193,734 87,750 47,417
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$112,899K Cash and cashequivalents$71,317K Inventory, net$1,826K Accounts receivable, net$1,605K License receivable$1,546K Other receivables$1,425K Prepaid expenses$1,210K Research and developmenttax credits...$425K Total current assets$192,253K Operating leaseright-of-use assets$981K Property and equipment,net$500K Total assets$193,734K Total liabilities andshareholders' equity$193,734K Total liabilities$157,685K Total shareholders'equity$36,049K Accumulated deficit-$456,669K Royalty financingobligation, long-term$78,111K Senior securedconvertible notes$58,192K Total currentliabilities$20,944K Operating leaseliabilities, net of current...$366K Other long-termliabilities$72K Common shares, no parvalue, unlimited...$373,702K Additional paid-in capital$63,367K Pre-funded warrants -16,412,925 issued and...$55,649K Accounts payable$10,023K Accrued liabilities$9,803K Operating leaseliabilities$659K Deferred revenue$416K Other currentliabilities$43K

Milestone Pharmaceuticals Inc. (MIST)

Milestone Pharmaceuticals Inc. (MIST)